Join Rob Bootle as he explores his journey at Nanopharm, highlighting the company’s cutting-edge research and development in orally inhaled and nasal drug products (OINDPs). Discover the innovative approaches to nasal sprays, and learn about the significant strides being made in transitioning to environmentally friendly, low-global warming potential (GWP) propellants in pressurized metered-dose inhalers (pMDIs). Nanopharm’s commitment to advancing pharmaceutical technologies and delivering client-focused solutions is at the forefront of Rob’s discussion.
Innovation & Insights
Interview with Jane Provis Evans, Head cGMP services at Nanopharm
In the ever-evolving world of pharmaceuticals, the importance of stringent quality control cannot be overstated. This interview with Jane Provis-Evans, Head of cGMP Analysis at Nanopharm, sheds light on the critical role of cGMP testing in the development and optimization of drug-device combinations, particularly for orally inhaled and nasal drug products (OINDPs). With the launch of Nanopharm’s new GMP services, the company is well-positioned to help clients bring innovative treatments to patients.
October 10, 2024
No Comments
